Uta Lichter‐Konecki

2.2k total citations
35 papers, 1.1k citations indexed

About

Uta Lichter‐Konecki is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Uta Lichter‐Konecki has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Clinical Biochemistry, 17 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Uta Lichter‐Konecki's work include Metabolism and Genetic Disorders (28 papers), Diet and metabolism studies (10 papers) and Neonatal Health and Biochemistry (7 papers). Uta Lichter‐Konecki is often cited by papers focused on Metabolism and Genetic Disorders (28 papers), Diet and metabolism studies (10 papers) and Neonatal Health and Biochemistry (7 papers). Uta Lichter‐Konecki collaborates with scholars based in United States, Germany and Canada. Uta Lichter‐Konecki's co-authors include Ulrich Langenbeck, Nenad Blau, Julia B. Hennermann, George A. Díaz, Brendan Lee, Harvey L. Levy, Yuval E. Landau, Marc Yudkoff, Jean‐Marie Mangin and Eric P. Hoffman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Cell Science.

In The Last Decade

Uta Lichter‐Konecki

34 papers receiving 1.1k citations

Peers

Countries citing papers authored by Uta Lichter‐Konecki

Since Specialization

Citations

This map shows the geographic impact of Uta Lichter‐Konecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uta Lichter‐Konecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uta Lichter‐Konecki more than expected).

Fields of papers citing papers by Uta Lichter‐Konecki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uta Lichter‐Konecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uta Lichter‐Konecki. The network helps show where Uta Lichter‐Konecki may publish in the future.

Co-authorship network of co-authors of Uta Lichter‐Konecki

This figure shows the co-authorship network connecting the top 25 collaborators of Uta Lichter‐Konecki. A scholar is included among the top collaborators of Uta Lichter‐Konecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uta Lichter‐Konecki. Uta Lichter‐Konecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Initial results from the PHEFREE longitudinal natural history study: Cross-sectional observations in a cohort of individuals with phenylalanine hydroxylase (PAH) deficiency 2024 ·Molecular Genetics and Metabolism ·Shawn E. Christ, Georgianne L. Arnold, Uta Lichter‐Konecki, Susan A. Berry, Dorothy K. Grange, Cary O. Harding, Elaina Jurecki, Harvey L. Levy, Nicola Longo, (unknown), Stephanie Sacharow, Janet A. Thomas, Desirée A. White	0
2	Health-related quality of life in a systematically assessed cohort of children and adults with urea cycle disorders 2023 ·Molecular Genetics and Metabolism ·Chaya N. Murali, John R. Barber, Robert McCarter, (unknown), Natalie M. Gallant, (unknown), Naghmeh Dorrani, Greta Wilkening, Ron D. Hays, Uta Lichter‐Konecki, Lindsay C. Burrage, Sandesh C.S. Nagamani	4
3	Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders 2020 ·Molecular Genetics and Metabolism ·Nicola Longo, George A. Díaz, Uta Lichter‐Konecki, Andreas Schulze, Michal Inbar‐Feigenberg, Robert L. Conway, (unknown), Shawn E. McCandless, Roberto T. Zori, Bryan E. Hainline, Nicholas Ah Mew, (unknown), Thomas Vescio, (unknown), Marty H. Porter, Susan A. Berry	10
4	Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients 2019 ·Molecular Genetics and Metabolism ·George A. Díaz, Andreas Schulze, Nicola Longo, William J. Rhead, Annette Feigenbaum, Derek A. Wong, J. Lawrence Merritt, William Berquist, Renata C. Gallagher, Dennis Bartholomew, Shawn E. McCandless, Wendy E. Smith, Cary O. Harding, Roberto Zori, Uta Lichter‐Konecki, Jerry Vockley, (unknown), Thomas Vescio, Robert J. Holt, Susan A. Berry	10
5	Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disorders 2018 ·Molecular Genetics and Metabolism ·Susan A. Berry, Jerry Vockley, Alexander A. Vinks, Min Dong, George A. Díaz, Shawn E. McCandless, Wendy E. Smith, Cary O. Harding, Roberto T. Zori, Can Fıçıcıoğlu, Uta Lichter‐Konecki, Renee Perdok, (unknown), Robert J. Holt, Nicola Longo	8
6	Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2 months to 2 years 2017 ·Molecular Genetics and Metabolism ·Susan A. Berry, Nicola Longo, George A. Díaz, Shawn E. McCandless, Wendy E. Smith, Cary O. Harding, Roberto T. Zori, Can Fıçıcıoğlu, Uta Lichter‐Konecki, (unknown), Jerry Vockley	14
7	Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate 2015 ·SHILAP Revista de lepidopterología ·Masoud Mokhtarani, George A. Díaz, Uta Lichter‐Konecki, Susan A. Berry, James Bartley, Shawn E. McCandless, Wendy E. Smith, Cary O. Harding, Cynthia Le Mons, Dion F. Coakley, B. Lee, Bruce F. Scharschmidt	3
8	Glycerol phenylbutyrate treatment in children with urea cycle disorders: Pooled analysis of short and long-term ammonia control and outcomes 2014 ·Molecular Genetics and Metabolism ·Susan A. Berry, Uta Lichter‐Konecki, George A. Díaz, Shawn E. McCandless, William J. Rhead, Wendy E. Smith, Cynthia LeMons, Sandesh C.S. Nagamani, Dion F. Coakley, Masoud Mokhtarani, Bruce F. Scharschmidt, Brendan Lee	27
9	What is in the can? The dilemma with dietary supplements 2014 ·Molecular Genetics and Metabolism ·Kristin D׳Aco, Robert A. Mooney, Kristina Cusmano‐Ozog, Sean Hofherr, Uta Lichter‐Konecki	3
10	Severe Neonatal Holocarboxylase Synthetase Deficiency in West African Siblings 2014 ·JIMD Reports ·Mauricio De Castro, Dina J. Zand, Uta Lichter‐Konecki, Brian Kirmse	6
11	Ammonia Control in Children Ages 2 Months through 5 Years with Urea Cycle Disorders: Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate 2013 ·The Journal of Pediatrics ·Wendy E. Smith, George A. Díaz, Uta Lichter‐Konecki, Susan A. Berry, Cary O. Harding, Shawn E. McCandless, (unknown), (unknown), Klara Dickinson, Dion F. Coakley, Tristen Moors, Masoud Mokhtarani, Bruce F. Scharschmidt, Brendan Lee	33
12	Population Pharmacokinetic Modeling and Dosing Simulations of Nitrogen‐Scavenging Compounds: Disposition of Glycerol Phenylbutyrate and Sodium Phenylbutyrate in Adult and Pediatric Patients with Urea Cycle Disorders 2013 ·The Journal of Clinical Pharmacology ·(unknown), Masoud Mokhtarani, George A. Díaz, William J. Rhead, Uta Lichter‐Konecki, Susan A. Berry, Cynthia LeMons, Klara Dickinson, Dion F. Coakley, B. Lee, Bruce F. Scharschmidt	29
13	Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies 2011 ·Molecular Genetics and Metabolism ·Nenad Blau, Julia B. Hennermann, Ulrich Langenbeck, Uta Lichter‐Konecki	177
14	MRI Features of 4 Female Patients With Pyruvate Dehydrogenase E1 alpha Deficiency 2011 ·Pediatric Neurology ·Nicholas Ah Mew, (unknown), Nadja Kadom, Uta Lichter‐Konecki, Andrea Gropman, (unknown), Adeline Vanderver	21
15	Complex management of a patient with a contiguous Xp11.4 gene deletion involving ornithine transcarbamylase: A role for detailed molecular analysis in complex presentations of classical diseases 2008 ·Molecular Genetics and Metabolism ·Matthew A. Deardorff, (unknown), Paige Kaplan, Pedro A. Sanchez‐Lara, Neal Sondheimer, Nancy B. Spinner, Håkon Håkonarson, Can Fıçıcıoğlu, Jaya Ganesh, Thomas C. Markello, Brett Loechelt, Dina J. Zand, Marc Yudkoff, Uta Lichter‐Konecki	19
16	Cross-sectional multicenter study of patients with urea cycle disorders in the United States 2008 ·Molecular Genetics and Metabolism ·Mendel Tuchman, Brendan Lee, Uta Lichter‐Konecki, Marshall Summar, Marc Yudkoff, Stephen D. Cederbaum, Douglas S. Kerr, George A. Díaz, (unknown), Hye Seung Lee, Robert McCarter, Jeffrey P. Krischer, Mark L. Batshaw	144
17	The Correlation of Genotype and Phenotype in Portuguese Hyperphenylalaninemic Patients 2000 ·Molecular Genetics and Metabolism ·Isabel Rivera, (unknown), Manuela Almeida, Paula Leandro, (unknown), (unknown), (unknown), Laura Vilarinho, Esmeralda Martins, Maria Celeste Lechner, Isabel Tavares de Almeida, David Konecki, Uta Lichter‐Konecki	14
18	Complete cDNA Sequence of Human Lysosome-Associated Membrane Protein-2 1994 ·Biochemical and Biophysical Research Communications ·David Konecki, Kay Foetisch, Magdalena Schlotter, Uta Lichter‐Konecki	12
19	The phenylketonuria G272X haplotype 7 mutation in European populations 1993 ·Human Genetics ·Jaran Apold, Hans Geir Eiken, Elisabeth Svensson, (unknown), Libor Kozák, (unknown), F. G�ttler, Jacques C. Giltay, Uta Lichter‐Konecki, (unknown), (unknown)	7
20	3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects 1992 ·The Journal of Pediatrics ·K. Michael Gibson, Malcolm J. Bennett, Charles E. Mize, C. Jakobs, Agnès Rötig, Arnold Münnich, Uta Lichter‐Konecki, Friedrich K. Trefz	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact